F11.29
Opioid dependence with unspecified opioid-induced disorder
Clinical Classification Guidelines
Medical Intelligence & Overview
ICD-10 code F11.29 refers to a condition characterized by dependence on opioids, combined with an opioid-induced disorder that has not been specifically identified. This condition reflects a complex situation where an individual has developed a physiological and psychological reliance on opioids, experiencing subsequent health issues due to their use. Opioids are a class of drugs prescribed for pain relief, but misuse or prolonged use can lead to dependence and various health complications. Recognizing and understanding this diagnosis helps in managing and treating the condition effectively.
Causes & Symptoms
Clinical Causes: Long-term use or misuse of prescription opioids Regular consumption of illicit opioids like heroin Inadequate pain management leading to increased reliance on opioids Genetic predisposition to substance dependence Psychological factors such as stress, trauma, or mental health disorders
Key Symptoms: Craving opioids or a strong desire to use Inability to control or reduce opioid intake despite negative consequences Tolerance, requiring higher doses to achieve the same effect Withdrawal symptoms when not taking opioids, such as sweating, tremors, nausea, or anxiety Neglect of responsibilities and activities due to opioid use Continued use despite health problems or social issues
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves a thorough medical evaluation, including patient history and physical examination. Healthcare providers may use specific screening tools and criteria to assess dependence and the effects of opioid use. Laboratory tests, such as urine or blood analysis, can help detect the presence of opioids and related substances. In this case, the disorder is unspecified, indicating that the precise type or cause of the opioid-induced disorder has not been clearly identified by the healthcare provider.
Treatment Protocols: Medication-Assisted Treatment (MAT): Using medications such as methadone, buprenorphine, or naltrexone to reduce cravings and withdrawal symptoms. Behavioral therapies: Counseling, cognitive-behavioral therapy (CBT), and support groups help address psychological aspects and promote recovery. Detoxification programs: Supervised withdrawal to manage symptoms safely and reduce physical dependence. Support for co-occurring mental health conditions: Treating underlying or concurrent mental health issues like depression or anxiety. Education and relapse prevention strategies: Equipping patients with skills to maintain sobriety and handle triggers.
Clinical Advice & FAQs
Billing Guidance
Is F11.29 a billable ICD-10 code?
Yes, F11.29 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report F11.29?
Clinical documentation must specify the nature of Opioid dependence with unspecified opioid-induced disorder and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
